FAM3A and metabolic dysfunction-associated steatotic liver disease: Another study found that under the condition of obesity, activation of the hepatic NFE2/miR-423-5p axis plays important roles in the progression of type 2 diabetes and NAFLD by repressing the FAM3A-ATP-Akt signaling pathway [29].